After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Crinetics Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Crinetics Pharmaceuticals Inc is $3.42B. A total of 0.59 million shares were traded on the day, compared to an average of 835.69K shares.
In the most recent transaction, Pizzuti Dana sold 5,000 shares of CRNX for 39.07 per share on Feb 03 ’25. After the transaction, the Chief Med and Dev Officer now owns 31,748 company shares. In a previous transaction on Feb 03 ’25, DANA J PIZZUTI bought 5,000 shares at 39.07 per share.
Among the insiders who sold shares, Pizzuti Dana disposed of 15,000 shares on Jan 03 ’25 at a per-share price of $52.09. This resulted in the Chief Med and Dev Officer holding 29,248 shares of CRNX after the transaction. In another insider transaction, DANA J PIZZUTI bought 15,000 shares at $52.09 per share on Jan 03 ’25.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, CRNX has a high of $62.53 and a low of $34.07.
As of this writing, CRNX has an earnings estimate of -$0.89 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of -$0.7 per share and a lower estimate of -$1.15.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. CRNX’s latest balance sheet shows that the firm has $333.71M in Cash & Short Term Investments as of fiscal 2021. There were $3.07M in debt and $15.99M in liabilities at the time. Its Book Value Per Share was $10.30, while its Total Shareholder’s Equity was $331.94M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRNX is Buy with a score of 4.87.
